Privia Health Group, Inc. (PRVA) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Privia Health Group, Inc. (PRVA) Healthcare & Pipeline Overview

Privia Health Group, Inc. is a national physician-enablement company optimizing healthcare delivery through technology and collaborative partnerships. The company enhances physician practices, improves patient experiences, and supports value-based care models. With a focus on in-person and virtual care settings, Privia operates in the healthcare information services sector.

What Is the Investment Thesis for PRVA?

With a market capitalization of $2.56B and a P/E ratio of 90.57, the company demonstrates significant earnings potential. A key value driver is its ability to optimize physician practices and enhance patient experiences, leading to improved outcomes and cost efficiencies. Growth catalysts include the increasing adoption of value-based care models and the expansion of its network of providers and payers. The company's technology and population health tools provide a competitive advantage, streamlining workflows and facilitating better care coordination. However, potential risks include regulatory changes in the healthcare sector and competition from other physician-enablement companies. The company's ongoing focus on innovation and strategic partnerships is expected to drive long-term growth and shareholder value.

Based on FMP financials and quantitative analysis

PRVA Key Highlights

Market capitalization of $2.56B indicates substantial investor confidence in Privia Health's business model and growth prospects.

• P/E ratio of 90.57 suggests the company is undervalued relative to its earnings, potentially offering an attractive entry point for investors.
• Gross margin of 9.6% reflects the company's ability to generate revenue from its services, although there is room for improvement compared to industry peers.
• Profit margin of 1.0% indicates profitability, highlighting the effectiveness of its physician-enablement platform.
• Beta of 0.87 suggests lower volatility compared to the overall market, making it a potentially stable investment option.

Who Are PRVA's Competitors?

PRVA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are PRVA's Key Strengths?

Established network of providers and payers.

• Proprietary technology platform.
• Expertise in value-based care.
• Strong reputation for improving patient outcomes.

What Are PRVA's Weaknesses?

Relatively low gross margin compared to industry peers.

• Dependence on regulatory changes in the healthcare sector.
• Limited geographic diversification.
• Potential for competition from larger healthcare technology companies.

What Could Drive PRVA Stock Higher?

Expansion of value-based care contracts with major payers, driving revenue growth and improved profitability.

• Strategic partnerships with large health systems to integrate Privia Health's platform and services.
• Launch of new technology solutions aimed at streamlining workflows and enhancing patient engagement.
• Continued investment in data analytics to improve patient outcomes and reduce costs.

What Are the Key Risks for PRVA?

Financial-distress signal — its Altman Z-Score of 0.18 sits in the distress zone (elevated bankruptcy risk).

• Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.
• Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
• Regulatory changes in the healthcare sector could impact Privia Health's business model and revenue streams.
• Increased competition from other physician-enablement companies and healthcare technology providers.
• Cybersecurity risks and data breaches could compromise patient data and damage the company's reputation.
• Economic downturn affecting healthcare spending could reduce demand for Privia Health's services.

What Are the Growth Opportunities for PRVA?

• Growth opportunity 1: Expansion of Value-Based Care Models: The increasing adoption of value-based care models presents a significant growth opportunity for Privia Health. As healthcare providers and payers shift towards rewarding outcomes rather than volume, Privia's platform, which optimizes physician practices and enhances patient experiences, becomes increasingly valuable. The market for value-based care is projected to reach $1 trillion by 2028, offering substantial revenue potential for Privia Health as it expands its network and service offerings. This expansion will be ongoing.
• Growth opportunity 2: Strategic Partnerships with Health Systems: Forming strategic partnerships with health systems allows Privia Health to extend its reach and integrate its services into larger healthcare networks. These partnerships can drive patient volume, enhance care coordination, and improve financial performance for both Privia Health and its partners. The market for healthcare partnerships is growing at an annual rate of 8%, providing a steady stream of opportunities for Privia Health to expand its footprint. This is an ongoing opportunity.
• Growth opportunity 3: Technological Innovation and Platform Enhancement: Continuous investment in technological innovation and platform enhancement is crucial for Privia Health to maintain its competitive edge. By developing new tools and features that streamline workflows, improve patient engagement, and enhance data analytics, Privia Health can attract new customers and retain existing ones. The healthcare technology market is projected to reach $390 billion by 2027, indicating a significant opportunity for Privia Health to capitalize on technological advancements. This is an ongoing opportunity.
• Growth opportunity 4: Expansion into New Geographic Markets: Expanding into new geographic markets represents a significant growth opportunity for Privia Health. By targeting regions with a high concentration of independent physicians and a growing demand for value-based care, Privia Health can increase its market share and revenue. The US healthcare market is vast and diverse, with each region presenting unique opportunities and challenges. This expansion will be ongoing.
• Growth opportunity 5: Leveraging Data Analytics for Improved Outcomes: Utilizing data analytics to improve patient outcomes and reduce costs is a key growth driver for Privia Health. By analyzing patient data, identifying trends, and implementing targeted interventions, Privia Health can enhance the quality of care and drive financial efficiencies. This is an ongoing opportunity.

What Are PRVA's Competitive Advantages?

• Proprietary technology platform that streamlines workflows and enhances patient engagement.
• Established network of physician practices, health plans, and health systems.
• Expertise in value-based care models and data analytics.
• Strong reputation for improving patient outcomes and reducing healthcare costs.

What Does PRVA Do?

Founded in 2007 and headquartered in Arlington, Virginia, Privia Health Group, Inc. emerged as a physician-enablement company, initially a subsidiary of Brighton Health Group Holdings, LLC. Privia Health collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care effectively. The company offers a suite of technology and population health tools designed to streamline independent providers' workflows. These tools include management services organization (MSO) offerings that reduce administrative burdens, allowing providers to focus on patient care. Privia also operates a single-TIN medical group, facilitating payer negotiation, clinical integration, and alignment of financial incentives. Its accountable care organization (ACO) engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care. Furthermore, Privia offers a network for purchasers and payers, enabling providers to connect with new patient populations and establish custom contracts. Privia Health's comprehensive platform supports a transition towards value-based care, improving outcomes and efficiency across the healthcare ecosystem. The company's national presence and integrated services position it as a key player in the evolving healthcare landscape.

What Products and Services Does PRVA Offer?

• Privia Health operates as a physician-enablement company.
• They collaborate with medical groups, health plans, and health systems.
• Privia optimizes physician practices to improve efficiency and patient care.
• The company enhances patient experiences through technology and personalized care.
• Privia rewards doctors for delivering high-quality care in both in-person and virtual settings.
• They offer technology and population health tools to streamline workflows.
• Privia provides management services to reduce administrative burdens on providers.

How Does PRVA Make Money?

• Privia Health generates revenue by providing technology and management services to physician practices.
• The company earns fees from health plans and health systems for improving care coordination and patient outcomes.
• Privia benefits from value-based care arrangements, where it shares in the cost savings generated by its services.

What Industry Does PRVA Operate In?

Privia Health Group, Inc. operates within the rapidly evolving healthcare information services industry, which is experiencing significant growth due to the increasing demand for efficient and value-based care solutions. The market is driven by factors such as the aging population, rising healthcare costs, and the shift towards preventative care. Privia Health competes with other physician-enablement companies and healthcare technology providers, navigating a landscape characterized by technological innovation and regulatory changes. The company's focus on optimizing physician practices and enhancing patient experiences positions it favorably in this competitive environment.

Who Are PRVA's Key Customers?

• Independent physician practices seeking to improve efficiency and patient care.
• Health plans looking to enhance care coordination and reduce costs.
• Health systems aiming to optimize their network of providers and improve patient outcomes.

Privia Health Group, Inc. (PRVA) Valuation Context

Valued at $2.56B, PRVA is classified as a mid-cap stock. Analyst price targets span from $24.00 to $32.00, with a consensus of $27.33. At the current price of $20.35, that implies approximately 34% upside potential. Relative to its peer group, PRVA's quantitative score of 35/100 is below the peer average of 64/100.

PRVA Revenue & Earnings Trend

In Q2 FY2026, PRVA generated $632.6M in top-line revenue, marking a sequential increase of 4.8%. The company recorded net income of $9.0M, with diluted EPS of $0.07. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this mid-cap Healthcare company. Across the four most recent quarters, PRVA averaged $0.05 in diluted EPS.

Company Profile

Privia Health Group, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Arlington, US. The company is led by CEO Parth Mehrotra. PRVA has traded publicly since 2021.

Return on equity for Privia Health Group, Inc. stands at 3.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 1.5%, showing how much profit it generates from its asset base. PRVA trades at a trailing price-to-earnings ratio of 90.57, above the Healthcare sector average of ~21.50x. Its free cash flow yield is 4.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.61 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 0.7%, the inverse of the P/E and a quick read on earnings relative to price.

Privia Health Group, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 0.18 places it in the distress zone, a signal of elevated financial risk.

Privia Health Group, Inc. has missed Wall Street's EPS estimate in 6 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 25.3% below estimates on average.

Over the past six months, Privia Health Group, Inc. insiders filed 57 SEC Form 4 transactions — 37 sales and 20 purchases. On net that is roughly 482K shares disposed (about $14.3M), a signal worth weighing alongside the fundamentals.

PRVA Financials

PRVA Latest News

PRVA Analyst Consensus

PRVA MoonshotScore

Privia Health Group, Inc. Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources